Biologics, Case Law, Covid-19, Damages, Infringement, Inventive step, Patents, United Kingdom, Validity

(Bristows)/ /1 Comment

Moderna secured a double victory in the Patents Court last week (2 July 2024) in proceedings against Pfizer and BioNTech.  In the first decision, Meade J found its modified mRNA patent to be valid and infringed by Pfizer and BioNTech’s “Comirnaty” vaccine.  In the second decision, Richards J rejected Pfizer and BioNTech’s defence based on…

Procedure, UPC

(Bristows)/

On 24 April 2024, the UPC’s Central Division in Paris granted Nicoventures Trading Limited access to written pleadings and evidence under RoP 262.1(b) in a patent revocation case brought by NJOY Netherlands B.V. against Juul Labs International, Inc (ORD_587436/2023 in UPC_CFI_316/2023). Nicoventures had made the document access request on 15 November 2023, however the Paris…